This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Teklegiorgis Ghebremariam: Innovator in Immunotherapy
Introduction
Teklegiorgis Ghebremariam is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of immunotherapy, particularly in the diagnosis and treatment of fungal conditions.
Latest Patents
Ghebremariam holds a patent for his invention titled "Immunotherapy and diagnosis of mucormycosis using CotH." This invention provides Mucorales CotH polypeptides and encoding nucleic acid molecules. The Mucorales CotH polypeptides and encoding nucleic acids can be advantageously used to diagnose, treat, or prevent fungal conditions, especially mucormycosis. He has 1 patent to his name.
Career Highlights
Ghebremariam is affiliated with the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work focuses on advancing medical research and developing innovative solutions for complex health issues.
Collaborations
Some of his notable coworkers include Ashraf S Ibrahim and Mingfu Liu, who contribute to the collaborative efforts in research and development within the institute.
Conclusion
Teklegiorgis Ghebremariam's work in immunotherapy represents a significant advancement in the fight against fungal infections. His innovative approach and dedication to research continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile